• Boucraut-Baralon C
  • PV 271
  • Décembre 2006
  • : Chien, chat

1 - BANDECCHI P, DELL'OMODARME M, MAGI M et coll. Feline leukemia virus (FeLV) and feline immunodeficiency virus infections in cats in the Pisa district of Tuscany, and attempts to control FeLV infection in a colony of domestic cats by vaccination. Vet. Rec. 2006; 158(16): 555-557.
2 - BISHOP SA, WILLIAMS NA, GRUFFYDD-JONES TJ et coll. Impaired T-cell priming and proliferation in cats infected with feline immunodeficiency virus. AIDS. 1992;6(3):287-293.
3 - BUONAVOGLIA C, MARSILIO F, TEMPESTA M et coll. Use of a feline panleukopenia modified live virus vaccine in cats with primary-stage of feline immunodeficiency virus infection. Zentralbl. Veterinarmed B. 1993;40:343-346.
4 - DAWSON S, SMYTH NR, BENNETT M et coll. Effect of primary-stage feline immunodeficiency virus infection on subsequent feline calicivirus vaccination and challenge in cats. AIDS. 1991;5(6):747-750.
5 - DEAN GA, LAVOY A, YEARLEY J, STANTON C. Cytokine modulation of the innate immune response in feline immunodeficiency virus-infected cats. J. Infect. Dis. 2006;193(11):1520-1527.
6 - DORNY P, SPEYBROECK N, VERSTRAETE S et coll. Serological survey of Toxoplasma gondii, feline immunodeficiency leukaemia virus in urban stray cats in Belgium. Vet. Rec. 2002; 151(21):626-629.
7 - HOFFMANN-LEHMANN R, HOLZNAGEL E, AUBERT A et coll. Recombinant FeLV-vaccine: long-term protection and effect on course and outcome of FIV infection. Vet. Immunol. Immunopathol. 1995;46(1-2):127-137.
8 - HOSIE MJ, OSBORNE R, REID G et coll. Enhancement after feline immunodeficiency virus vaccination. Vet. Immunol. Immunopathol. 1992;35(1-2): 191-197.
9 - LEHMANN R, VON BEUST B, NIEDERER E et coll. Immunization-induced decrease of the CD4+/CD8+ ratio in cats experimentally infected with feline immunodeficiency virus. Vet. Immunol. Immunopathol. 1992;35(1-2):199-214.
10 - LEVY JK, SCOTT HM, LACHTARA JL, CRAWFORD PC. Seroprevalence of feline leukaemia virus and feline immunodeficiency virus infection among cats in North America and risk factors for seropositivity. J. Am. Vet. Med. Assoc. 2006;228:371-376.
11 - MALIK R, KENDALL K, CRIDLAND J et coll. Prevalence of feline leukaemia virus and feline immunodeficiency virus infections in cats in Sydney. Aust. Vet. J. 1997; 75(5):323-327.
12 - MARUYAMA S, KABEYA H, NAKAO R et coll. Toxoplasma gondii, FIV and FeLV infections in domestic cats in Japan. Microbiol. Immunol. 2003;47(2): 147-153.
13 - MUIRDEN A. Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus and feline coronavirus in stray cats sent to RSPCA hospital. Vet. Rec. 2002;150:621-625.
14 - REUBEL GH, DEAN GA, GEORGE JW et coll. Effects of incidental infections and immune activation on disease progression in experimentally feline immunodeficiency virus-infected cats. J. Acquir. Immune Defic. Syndr. 1994;7(10):1003-1015.
15 - REUBEL GH, GEORGE JW, BARLOUGH JE et coll. Interaction of acute feline herpesvirus-1 and chronic feline immunodeficiency virus infections in experimentally infected specific pathogen free cats. Vet. Immunol. Immunopathol. 1992;35(1-2):95-119.
16 - REUBEL GH, GEORGE JW, HIGGINS J et coll. Effect of chronic feline immunodeficiency virus infection on experimental feline calicivirus-induced disease. Vet. Microbiol. 1994;39(3-4):335-351.
17 - SHIMOJIMA M, MIYAZAWA T, IKEDA Y et coll. Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science. 2004; 303(566):1192-1195.

Sites internet
http://www.abcd-vets.org
http://www.aafponline.org/resources/practice_guidelines.htm


En poursuivant votre navigation sur ce site, vous acceptez l’utilisation de cookies pour vous proposer des services et offres adaptés à vos centres d’intérêts.X
Pour en savoir plus et paramétrer les cookies...